http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008030624-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79da8d457a2e1f70413a9e1cb2efaf29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4bc31573a86be92b723bc424b20d68ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25ab3f48716df9f405ba042e1f25f300
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6636b59c3149a23a6ae7feaa3984d05f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff81a650b70e913d3b2524b45e4c7320
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3ec15981c4c9238c95705f6af3c56ee
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-2982
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-582
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0093
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01B33-141
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-585
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C01B33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82B1-00
filingDate 2007-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68272d9eca8453c0ff39697b8385a08a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfceb089528678dc77c80481c73e72b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20ebd3aafb8b950bdbe57bbe8c6248b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91074dfd918a017a880a564faed49296
publicationDate 2008-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2008030624-A3
titleOfInvention Nanoparticles for two-photon activated photodynamic therapy and imaging
abstract The present invention provides organically modified silica (ORMOSIL) nanoparticles into which have been incorporated two-photon absorption dye molecules. The two photon absorption dye displays a unique aggregation induced fluorescence enhancement behavior. As a result ORMOSIL nanoparticles with high amounts of the dye can be prepared. These particles can be used for imaging. In one embodiment, the nanoparticles can additionally have incorporated therein a photosensitizer. The photosensitizer can be activated by intraparticle fluorescence resonance energy transfer (FRET) from the dye aggregates resulting in enhanced fluorescence and singlet oxygen generation from photosensitizer under two-photon excitation conditions. Such nanoparticles can be used for photodynamic therapy applications.
priorityDate 2006-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005124712-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7005229-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004180096-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006182992-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977

Total number of triples: 35.